Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis

This study has been completed.
Sponsor:
Collaborator:
European Commission
Information provided by (Responsible Party):
Chiesi Farmaceutici S.p.A. ( Zymenex A/S )
ClinicalTrials.gov Identifier:
NCT01681953
First received: August 22, 2012
Last updated: March 28, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):